TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Western Health & Social Care Trust: "SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityWestern Health & Social Care TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Western Health & Social Care Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Western Health & Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 9 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published8 Dec 2025, 12:50 GMT
Last source update8 Dec 2025, 12:50 GMT
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-05ddfe
What is being bought
Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
What changed
From the official release history
  1. Official notice release published
    8 Dec 2025, 12:50 GMT
  2. Official notice release published
    10 Nov 2025, 16:36 GMT
  3. Status changed to complete
    10 Nov 2025, 15:58 GMT
  4. Official notice release published
    10 Nov 2025, 15:58 GMT
  5. Buyer information updated
    10 Nov 2025, 15:58 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    8 Dec 2025, 12:50 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 14 Nov 2025, 00:00 GMT · £4,638,166
Commercial outcome and competition
Awards
NOVARTIS PHARMACEUTICALS UK LIMITED
Not published · Not published · active
Contracts
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
£4,638,166 · signed 14 Nov 2025, 00:00 GMT · active
Contract period: 1 Dec 2025, 00:00 GMT30 Nov 2028, 23:59 GMT
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Western Health & Social Care Trust

Contracting authority GB-PPON-PTVW-2397-PWCT
View buyer profile
  • Western Health & Social Care Trust
    buyer

    GB-PPON: PTVW-2397-PWCT
    Altnagelvin Area Hospital, Glenshane Road, Londonderry, UKN0A, BT47 6SB, GB
    02871345171 213710
  • NOVARTIS PHARMACEUTICALS UK LIMITED
    supplier

    GB-COH: 00119006 · GB-PPON: PJTX-5182-QVLR
    2nd Floor, The Westworks Building White City Place, London, UKI33, W12 7FQ, GB
Documents (1)
Official links; attachments are not copied
  • Not published

    tender
    conflictOfInterest
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleSection 41 of the PA2023, permits a direct award in specific cases. Schedule 5 of the PA2023 sets out justifications for direct award - this particular supplier having intellectual property rights or other exclusive rights, only this supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works